Latest Clinical & Research News
In a prespecified secondary analysis of the DELIVER trial, Scott D. Solomon, MD, at Brigham and Women’s Hospital, and colleagues found that starting dapagliflozin during or shortly after hospitalization for HF is safe and effective for patients with mildly reduced or preserved ejection fraction.
Read More...
Giovanna S. Manzano, MD, of the Department of Neurology at Brigham and Women’s Hospital, Marcelo Matiello, MD, of Massachusetts General Hospital, and colleagues determined positive predictive values of a live cell–based serum assay that detects the diagnostic biomarker for MOG-AD in a real-world cohort.
Read More...
In a large randomized trial, Howard D. Sesso, ScD, MPH, associate director of the Division of Preventive Medicine, and colleagues determined vitamin C supplementation was associated with a lower risk of new gout diagnosis in adult men, whereas supplemental vitamin E had no effect.
Read More...
Caroline M. Apovian, MD, and team determined that the variability of weight loss and hemoglobin A1C across racial/ethnic groups was small after Roux-en-Y gastric bypass (RYGB) compared with sleeve gastrectomy (SG). However, safety concerns were greater for Black and Latino patients after RYGB than SG.
Read More...
As part of the United Against Racism initiative, Mass General Brigham implemented outreach programs across the system to reduce healthcare disparities. Quoc-Dien Trinh, MD, MBA, discusses the program he co-founded and the research his team is doing to improve care for people of color at Brigham and Women’s Hospital.
Read More...
Select patients with complex ventral hernias may benefit from a technique that employs Botox injections to relax the abdominal muscles before surgery, enabling the surgeon to complete the hernia repair less invasively. The Brigham’s Eric G. Sheu, MD, PhD, and Daniel I. Glazer, MD, discuss the benefits of this approach.
Read More...
In COVID-PACT, a 2×2 factorial, randomized, controlled trial that enrolled critically ill patients with COVID-19, researchers at Brigham and Women’s Hospital determined full-dose anticoagulation was superior to standard-dose prophylaxis in reducing the proportion of patients experiencing a thrombotic event.
Read More...
Brigham investigators have mapped out a group of cells in the trigeminal ganglia that drive migraine pain, allowing them to further characterize the cells in a way that holds promise for developing new therapeutics. Neurologist and lead author William R. Renthal, MD, PhD, elaborates on the study.
Read More...
Implantable devices for drug delivery to the bladder require surgical implantation and removal. Scientists at Brigham and Women’s Hospital have invented a biodegradable ring-shaped implantable device (BRID) for long-term and local drug delivery inside the bladder that does not require a retrieval procedure.
Read More...
Creating kidney organoids for preclinical research poses a challenge due to their complex architecture. Brigham researchers have developed an efficient method for generating functional ureteric bud and collecting ducts organoids, which drive the growth and radial organization of the developing kidney.
Read More...